Sylvia K Plevritis

发表

DRUG-NEM: Optimizing drug combinations using single-cell perturbation response to account for intratumoral heterogeneity

Robert Tibshirani, Garry P Nolan, Kara L Davis, 2018, Proceedings of the National Academy of Sciences.

MiDReG: A method of mining developmentally regulated genes using Boolean implications

Debashis Sahoo, Sylvia K Plevritis, Jun Seita, 2010, Proceedings of the National Academy of Sciences.

Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma.

Ash A. Alizadeh, Hanlee P. Ji, Michael R Green, 2012, Blood.

A pluripotency signature predicts histologic transformation and influences survival in follicular lymphoma patients.

Babak Shahbaba, Catherine M Shachaf, Ash A. Alizadeh, 2009, Blood.

A comparative review of CISNET breast models used to analyze U.S. breast cancer incidence and mortality trends.

Eric J Feuer, Kathleen A Cronin, Sylvia K Plevritis, 2006, Journal of the National Cancer Institute. Monographs.

Cost-effectiveness of screening BRCA1/2 mutation carriers with breast magnetic resonance imaging.

Bruce L Daniel, Sylvia K Plevritis, Debra M Ikeda, 2006, JAMA.

Lymphomas that recur after MYC suppression continue to exhibit oncogene addiction

Kavya Rakhra, Sylvia K Plevritis, Andrew J Gentles, 2011, Proceedings of the National Academy of Sciences.

Clinical Guidelines Annals of Internal Medicine Effects of Mammography Screening Under Different Screening

Marvin Zelen, Harry J de Koning, Eric J Feuer, 2022 .

Online tool to guide decisions for BRCA1/2 mutation carriers.

Sylvia K Plevritis, Peter Rust, Lauren Clarke, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Non-small cell lung cancer: identifying prognostic imaging biomarkers by leveraging public gene expression microarray data--methods and preliminary results.

Olivier Gevaert, Daniel L Rubin, Sandy Napel, 2012, Radiology.

Risk prediction models for selection of lung cancer screening candidates: A retrospective validation study

Harry J de Koning, Ewout W Steyerberg, Jihyoun Jeon, 2017, PLoS medicine.

Mutations in early follicular lymphoma progenitors are associated with suppressed antigen presentation

Ash A. Alizadeh, Serafim Batzoglou, Michael R Green, 2015, Proceedings of the National Academy of Sciences.

Integrating Tumor and Stromal Gene Expression Signatures With Clinical Indices for Survival Stratification of Early-Stage Non-Small Cell Lung Cancer.

Ash A. Alizadeh, Maximilian Diehn, Sylvia K Plevritis, 2015, Journal of the National Cancer Institute.

Modeling the impact of population screening on breast cancer mortality in the United States.

Marvin Zelen, Harry J de Koning, Eric J Feuer, 2011, Breast.

Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012

Oguzhan Alagoz, Harry J de Koning, Xuelin Huang, 2018, JAMA.

Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortality.

Oguzhan Alagoz, Eveline A M Heijnsdijk, Harry J de Koning, 2014, Journal of the National Cancer Institute.

Boolean implication networks derived from large scale, whole genome microarray datasets

Robert Tibshirani, Debashis Sahoo, Sylvia K Plevritis, 2008, Genome Biology.

Non–Small Cell Lung Cancer Radiogenomics Map Identifies Relationships between Molecular and Imaging Phenotypes with Prognostic Implications

Olivier Gevaert, Daniel L Rubin, Sandy Napel, 2017, Radiology.

A radiogenomic dataset of non-small cell lung cancer

Olivier Gevaert, Daniel L Rubin, Sandy Napel, 2018, Scientific Data.

Prognostic PET 18F-FDG uptake imaging features are associated with major oncogenomic alterations in patients with resected non-small cell lung cancer.

Olivier Gevaert, Daniel L Rubin, Sandy Napel, 2012, Cancer research.

A natural history model of stage progression applied to breast cancer

Sylvia K Plevritis, Peter Salzman, Peter W Glynn, 2007, Statistics in medicine.